Prediabetes Market: Current Analysis and Forecast (2025-2033)
Emphasis on Product Type (Diagnostics & Devices, Pharmaceuticals & Therapeutics, Nutraceuticals & Functional Foods, and Others); Age Group (Children, Adults, and Elderly); End User (Hospitals & Clinics, Diagnostic Centers, Homecare Settings, and Others); and Region/Country
Global Prediabetes Market Size & Forecast
The Global Prediabetes Market was valued at USD 311.3 million in 2024 and is expected to grow to a strong CAGR of around 10.02% during the forecast period (2025-2033F), driven by rising global prevalence of obesity and sedentary lifestyles, which significantly increase the risk of type 2 diabetes.
Prediabetes Market Analysis
The prediabetes market is significantly progressing because of the increasing rates of its prevalence, the augmentation of awareness about the disease, and the changing trends in the global focus on preventive medicine. A sedentary lifestyle, improper diet, and increased prevalence of obesity have been emerging factors for the rise in the incidence of prediabetes, primarily in urban communities. Growing awareness of the risky consequences of untreated prediabetes, such as the development of type 2 diabetes and cardiovascular diseases, is driving early intervention strategies among patients and helping in the prediabetes treatment. Moreover, frequent physical checkups and modifications in lifestyle, such as having a prediabetes diet, represent two aspects that governments and other healthcare-related bodies are continuously encouraging, thus driving the market growth.
Global Prediabetes Market Trends
This section discusses the key market trends that are influencing the various segments of the global prediabetes market, as found by our team of research experts.
Rise in At-Home Testing Kits
Convenience and privacy are the biggest concerns that help to increase the popularity of at-home testing kits for prediabetes. These kits enable patients to test their blood glucose levels or HbA1c without the need for professional help, as well as by blood samples from a fingertip or saliva. The current advancement of smartphones and electronic health platforms enables users to get immediate feedback as well as consult with medical practitioners through technology, which further helps in the prediabetes treatment. This is especially so in rural or other areas that may not be within proximity of a diagnostic centre accessibility. As the general health consciousness of the population grows and as more and more people transition to online connections, more people are getting themselves tested early so they can correct their lifestyles sooner, start prediabetes medication, and are able to reverse prediabetes. Moreover, key players are engaging in launching innovative home kit solutions to discover the early signs of prediabetes.
Prediabetes Industry Segmentation
This section provides an analysis of the key trends in each segment of the global prediabetes market report, along with forecasts at the global, regional, and country levels for 2025-2033.
Diagnostics & Devices Segment Dominates the Prediabetes Market.
Based on product type, the market is segmented into diagnostics & devices, pharmaceuticals & therapeutics, nutraceutical & functional foods, and others. Among these, the diagnostics & devices segment has the highest market share. This dominance is due to the growing number of tools for early detection of diabetes, heightened consciousness among people about prediabetes management, and the increased use of blood glucose monitors, HbA1c testing kits, and CGM devices. However, the nutraceuticals & functional foods sector is expected to grow at the fastest rate in the future, due to the shift towards using natural healthcare solutions, and the use of dietary supplements and functional foods to control blood sugar levels.
Hospitals & Clinics Segment Dominates the Prediabetes Market.
Based on the end-user category, the global market is categorized into hospitals & clinics, diagnostic centers, homecare settings, and others. Among these, the hospitals & clinics segment has the largest market share. Major factors are increased patients' visits to hospitals, availability of enhanced diagnostic laboratories, and healthcare practitioners' specialization in early identification and treating prediabetes symptoms. However, the homecare settings segment is expected to show the highest CAGR in the future. This is due to the increase in the use of personal health monitoring devices, knowledge of preventive care, and developments in telemedicine and remote patient monitoring facilities.
The North America region holds a significant market share in the Global Prediabetes Market.
North America has a higher market demand for prediabetes due to factors such as a high prevalence of prediabetes, a well-developed healthcare sector, and increased awareness regarding early diagnosis and prevention. The North American population benefits from the ease of accessibility to diagnostics, digital health solutions, and lifestyle modification plans to facilitate early diagnosis and control. Additionally, government programs such as the National Diabetes Prevention Program (NDPP) under the Centers for Disease Control (CDC) also act as a driving force to enhance screening and awareness strategies. Moreover, high insurance penetration, better healthcare expenditure, and affiliations between healthcare and technology companies also contribute to market growth. Consumer awareness and adoption of wearable health devices also pave the way towards the increased market dominance of the region.
The U.S. held a Dominant share of the North American Prediabetes Market in 2024
The largest market for prediabetes is in the United States, as it has a large patient pool, the adoption of innovative health care technologies, and mainly increased government attention to preventive health care. Increased prevalence of the disease in the population, the use of screening tests such as HbA1c and CGM, and the timely diagnosis help to prevent the development of complications. Furthermore, the market’s strategic presence of large market stakeholders and large investments in digital therapeutics and health platforms based on artificial intelligence increases the country’s market potential. Other favorable reimbursement policies and public and private partnerships add to the app's accessibility to prediabetes management solutions, making the US the leading nation in the region.
Prediabetes Industry Competitive Landscape
The global prediabetes market is competitive, with several global and international market players. The key players are adopting different growth strategies to enhance their market presence, such as partnerships, agreements, collaborations, geographical expansions, and mergers and acquisitions.
Top Prediabetes Product Manufacturing Companies
Some of the major players in the market are Abbott Laboratories, F. Hoffmann-La Roche Ltd., Siemens Healthineers, Ascensia Diabetes Care, Omada Health, Noom, Inc., Eli Lilly and Company, PharmaLinea, Oramed, and Bayer AG.
Recent Developments in the Prediabetes Market
In August 2024 – Eli Lilly and Company announced the positive topline results from the SURMOUNT-1 three-year study (176-week treatment period) evaluating the efficacy and safety of tirzepatide. This drug is expected to reduce the risk of developing type 2 diabetes by 94% in adults with pre-diabetes and obesity or overweight.
In March 2023 – PharmaLinea launched “Prediabetiq Capsules,” a clinically supported private label food supplement designed to provide immediate improvement in glycemic response, measurable in real-time. The product was formulated with patented, award-winning, and clinically studied ingredients aimed at promoting balanced blood glucose levels and reducing insulin resistance.
Global Prediabetes Market Report Coverage
Report Attribute | Details |
Base year | 2024 |
Forecast period | 2025-2033 |
Growth momentum | Accelerate at a CAGR of 10.02% |
Market size 2024 | USD 311.3 Million |
Regional analysis | North America, Europe, APAC, Rest of the World |
Major contributing region | Asia-Pacific is expected to dominate the market during the forecast period. |
Key countries covered | U.S., Canada, Germany, U.K., Spain, Italy, France, China, Japan, and India |
Companies profiled | Abbott Laboratories, F. Hoffmann-La Roche Ltd., Siemens Healthineers, Ascensia Diabetes Care, Omada Health, Noom, Inc., Eli Lilly and Company, PharmaLinea, Oramed, and Bayer AG |
Report Scope | Market Trends, Drivers, and Restraints; Revenue Estimation and Forecast; Segmentation Analysis; Demand and Supply Side Analysis; Competitive Landscape; Company Profiling |
Segments Covered | By Product Type, By Age Group, By End-user, By Region/Country |
Reasons to Buy the Prediabetes Market Report:
The study includes market sizing and forecasting analysis confirmed by authenticated key industry experts.
The report briefly reviews overall industry performance at a glance.
The report covers an in-depth analysis of prominent industry peers, primarily focusing on key business financials, type portfolios, expansion strategies, and recent developments.
Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.
The study comprehensively covers the market across different segments.
Deep dive regional level analysis of the industry.
Customization Options:
The global Prediabetes market can further be customized as per the requirements or any other market segment. Besides this, UnivDatos understands that you may have your own business needs, hence feel free to contact us to get a report that completely suits your requirements.
Table of Contents
Research Methodology for the Global Prediabetes Market Analysis (2023-2033)
We analyzed the historical market, estimated the current market, and forecasted the future market of the global prediabetes market to assess its application in major regions worldwide. We conducted exhaustive secondary research to gather historical market data and estimate the current market size. To validate these insights, we carefully reviewed numerous findings and assumptions. Additionally, we conducted in-depth primary interviews with industry experts across the prediabetes value chain. After validating market figures through these interviews, we used both top-down and bottom-up approaches to forecast the overall market size. We then employed market breakdown and data triangulation methods to estimate and analyze the market size of industry segments and sub-segments.
Market Engineering
We employed the data triangulation technique to finalize the overall market estimation and derive precise statistical numbers for each segment and sub-segment of the global prediabetes market. We split the data into several segments and sub-segments by analyzing various parameters and trends, including product type, age group, end-user, and regions within the global prediabetes market.
The Main Objective of the Global Prediabetes Market Study
The study identifies current and future trends in the global prediabetes market, providing strategic insights for investors. It highlights regional market attractiveness, enabling industry participants to tap into untapped markets and gain a first-mover advantage. Other quantitative goals of the studies include:
Market Size Analysis: Assess the current and forecast market size of the global prediabetes market and its segments in terms of value (USD).
Prediabetes Market Segmentation: Segments in the study include areas of product type, age group, end-user, and region.
Regulatory Framework & Value Chain Analysis: Examine the regulatory framework, value chain, customer behavior, and competitive landscape of the prediabetes industry.
Regional Analysis: Conduct a detailed regional analysis for key areas such as Asia Pacific, Europe, North America, and the Rest of the World.
Company Profiles & Growth Strategies: Company profiles of the prediabetes market and the growth strategies adopted by the market players to sustain in the fast-growing market.
Frequently Asked Questions FAQs
Q1: What is the global prediabetes market’s current market size and growth potential?
As of 2024, the global prediabetes market is valued at approximately USD 311.3 million. It is projected to grow at a compound annual growth rate (CAGR) of 10.02% from 2025 to 2033, fueled by increasing obesity rates, sedentary lifestyles, and rising awareness of early-stage diabetes prevention.
Q2: Which segment has the largest share of the global prediabetes market by product type?
The diagnostics and devices segment currently holds the largest share of the global prediabetes market, driven by the growing demand for early detection tools like glucose monitors, point-of-care tests, and wearable health devices.
Q3: What are the driving factors for the growth of the global prediabetes market?
Key growth drivers include the rising global incidence of obesity, increased risk of type 2 diabetes, growing awareness of preventive healthcare, and the availability of digital health tools and lifestyle intervention programs. Government initiatives and tech-enabled screening solutions also support market expansion.
Q4: What are the emerging technologies and trends in the global prediabetes market?
Major trends include the adoption of continuous glucose monitoring (CGM), AI-powered health apps, and digital therapeutics platforms offering personalized care. There's also rising interest in GLP-1 receptor agonists, non-invasive diagnostic tools, and virtual health coaching for proactive disease management.
Q5: What are the key challenges in the global prediabetes market?
Significant challenges include low awareness and underdiagnosis, especially in developing regions, limited access to affordable care, and poor patient adherence to long-term lifestyle changes. These barriers affect timely diagnosis and effective disease prevention.
Q6: Which region dominates the global prediabetes market?
North America holds the largest market share due to advanced healthcare infrastructure, a high prevalence of prediabetes, strong adoption of diagnostics, and proactive government programs targeting early diabetes prevention.
Q7: Who are the key companies in the global prediabetes market?
Key players in the global prediabetes space include:
• Abbott Laboratories
• F. Hoffmann-La Roche Ltd.
• Siemens Healthineers
• Ascensia Diabetes Care
• Omada Health
• Noom, Inc.
• Eli Lilly and Company
• PharmaLinea
• Oramed
• Bayer AG.
Q8: What are the key investment opportunities in the global prediabetes market?
Investment opportunities in the prediabetes market lie in digital health platforms, wearable glucose monitoring devices, AI-driven diagnostic tools, and next-generation therapeutics. With rising disease prevalence and growing focus on early intervention, investors are increasingly backing innovative startups, strategic M&A activity, and R&D in drug development and non-invasive diagnostics.
Q9: What regulatory and reimbursement trends are shaping the prediabetes industry?
The prediabetes market is influenced by evolving regulatory frameworks promoting preventive healthcare and reimbursement policies that now increasingly cover digital therapeutics and screening tools. Supportive programs, particularly in the U.S. and Europe, are encouraging broader access to early intervention solutions, making the market more attractive to stakeholders.
Related Reports
Customers who bought this item also bought
Antibiotic Resistance Market: Current Analysis and Forecast (2024-2032)
Emphasis on Disease Type (Urinary Tract Infections, Intra-Abdominal Infections, Blood Stream Infections, Clostridium Difficile Infections, And Others); Pathogen Type (Acinetobacter baumannii, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus pneumoniae, and Others); Drug Class (Oxazolidinones, Lipoglycopeptides, Tetracyclines, and Others); and Region/Country
October 8, 2024
